Educational Activities Archives

The webinar is intended to explore practical strategies for preventing opioid, stimulant, and other substance use disorders among children and youth affected by addiction in their families and communities. Participants will learn how early exposure to substance use, chronic stress, and community conditions can increase vulnerability over time—and how protective factors like connection, stability, belonging, and healthy coping skills can reduce risk. The session highlights what families, schools, and community helpers can do early to support resilience and interrupt cycles of addiction before they take hold.

This episode examines how these newer compounds differ pharmacologically, why they are more dangerous, and how clinicians can recognize and respond to kratom-related harms. Listeners will gain practical strategies for identifying kratom use disorder, managing withdrawal, and having informed, non-stigmatizing conversations with patients as these products continue to emerge and change.

Join this 1.5‑hour live virtual session featuring a multidisciplinary panel discussing interprofessional approaches to opioid withdrawal assessment. Learn about validated tools to assess opioid withdrawal, and then, through real‑world case examples, discuss professional roles and apply key concepts to practice.

Join this 1.5‑hour live virtual session to delve into the emerging prevalence of medetomidine within the drug supply and strategies to manage medetomidine-opioid withdrawal syndrome. Participants will explore real‑world scenarios through case examples presented by addiction experts, applying key concepts to clinical practice.

Join this 1.5‑hour live virtual session to learn about common conditions that complicate opioid withdrawal management in emergency department and hospital settings. The session will address co‑occurring medical and psychiatric conditions and provide practical strategies for managing complex withdrawal cases. Participants will explore real‑world scenarios through case examples led by addiction experts, applying key concepts to clinical practice.

Stimulant use, including cocaine, methamphetamine and prescription stimulants, continues to be a growing and urgent public health concern. According to the 2024 National Survey on Drug Use and Health, 9 million people in the U.S. had used stimulants not as prescribed in the past year. Though opioids are often the focus of overdose conversations, stimulant-related overdose deaths reached an estimated 51,630 in 2024, while 59% of all overdoses from January 2021 through June 2024 involved a stimulant (Centers for Disease Control and Prevention, 2025). These trends underscore the critical need for effective treatment and engagement strategies. Several evidence-based behavioral therapies exist to help providers treat stimulant use disorder. This webinar will outline the clinical and administrative approaches to assess, treat and support people experiencing stimulant use disorder.